Estimating internal exposure or dose of dioxins and related chemicals such as dibenzofurans and dioxinlike polychlorinated biphenyls is relatively straightforward in laboratory animals because a known dose is given and the amount absorbed can be measured. In wildlife, direct tissue measurement and measurement of environmental samples have both recently been used to estimate exposure. Until recently, human studies used only indirect indicators such as skin lesions to qualitatively estimate exposure to these chlorinated organic compounds. Environmental measurements have also sometimes been used to estimate human exposure. Dioxins in human tissue were not measured until the 1970s, when 2,3,7,8-tetrachlorodibenzo-p-dioxin was measured in mothers' milk; congener-specific measurement of dioxins and dibenzofurans in tissues (blood, milk, and adipose tissue) of the general population and exposed workers was first performed in the United States in the 1 980s. Measurement in a sensitive and specific fashion of the 17 toxic dioxin and dibenzofuran congeners currently found in human tissue from industrial countries began in the 1980s. The use of known chemical standards, capillary columns, high resolution gas chromatography and mass spectrometry (GC-MS) has now become relatively common. GC-MS analysis of blood is currently accepted as the gold standard for estimating human exposure to dioxins. However, analyses are still costly and time consuming, and worldwide there are few qualified laboratories. There is currently a lack of knowledge concerning kinetics at higher and lower exposure levels for most of the toxic dioxin congeners and of levels in target tissues of concern.
Historical Review
Estimation of dose of polychlorinated dibenzo-p-dioxins (PCDDs) and related chemicals such as polychlorinated dibenzofurans (PCDFs) and polychlorinated biphenyls (PCBs) is relatively straightforward in animal toxicology studies. Dioxins are usually administered by gavage or added to food. The percent of absorption is calculated from measurements of the labeled compounds. In oily vehicles absorption is quite high, approaching 100%, whereas absorption is usually less in aqueous vehicles (1) (2) (3) (4) (5) (6) (7) .
For wildlife, congener-specific dioxin measurement in tissues, eggs, or environmental media is now frequently performed following discovery of a toxic end point such as eggshell thinning or malformations.
Because synthetic chemicals other than dioxins are also sometimes elevated, the association between the individual chemicals in a mixture and the toxic end point may be less clear than in laboratory studies using specific dosing regimens in animal models (8, 9) . For example, in addition to dioxins, dibenzofurans, DDT, and DDT metabolites, many PCB congeners are elevated in tissue or egg specimens.
Until recently, human health studies used only indirect measures to demonstrate human exposure to dioxins. These indirect measures were neither sensitive nor specific. Erythema, a reddish discoloration of the skin, or chloracne, acne usually found in a group of workers following exposure to synthetic chlorinated organics, were the most commonly observed signs indicating exposure to chlorinated organics, including dioxins. Although Herxheimer (10) described chloracne in workers exposed to organochlorines in the 19th century, it was not established until 1957 that dioxins can cause chloracne (11) .
The first human dioxin measurements were performed by Baughman in 1973 on breast milk collected in 1970 and 1973 (12) . Baughman compared 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) levels in the milk of Vietnamese women from two villages sprayed with Agent Orange contaminated with TCDD to those of women living in Massachusetts. TCDD was not detected with the limits of detection available at that time in the milk of the women from Massachusetts. Figure 1 (24) . Unlike some previous human tissue sampling for dioxin analyses, the adipose tissue was obtained by biopsy from living exposed veterans. Subsequent studies also found elevated TCDD in a relatively small percent of potentially exposed U.S. Vietnam veterans (25) (26) (27) (28) (29) (30) . Figure 3 presents the elevated levels of TCDD found in adipose tissue from six Massachusetts Vietnam veterans potentially exposed to Agent Orange (12, 25 (31, 33) . The work was repeated and extended shortly thereafter with improved specificity and sensitivity of congener detection (34) . Figure 4 shows total measured PCDD and PCDF levels from this study, which illustrates how the findings of elevated PCDF or PCDD congeners were used to document actual exposure in some potentially exposed Binghamton workers (12) . Figure 5 shows PCB levels reported as Aroclor 1254 in the serum of other workers (firefighters) shordy after their exposure during the Binghamton incident and 10 months later (35) . By 10 months after exposure, the PCB levels in the firefighters' serum were similar to those of the general population. This illustrates the rapid decrease in PCBs frequently observed after acute exposure and demonstrates the potential usefulness of immediate as well as serial blood testing after exposure. Had PCB levels been measured only once, 10 months after exposure, there would have been no evidence of elevated levels, so erroneous conclusions regarding exposure could easily have been made.
Epidemiology studies in the 1980s, and even in the 1990s, rarely used tissue measurement to estimate exposure to or dose of dioxins. This omission caused difficulties in exposure assessment. Two of the former common assumptions were that the majority of Vietnam veterans had exposure to Agent Orange and its dioxin contaminant, and that the general population did not have any dioxin exposure. It was eventually realized that both exposure assumptions were incorrect (19, 29, 36, 37 In the 1980s and early 1990s, exposure assessment studies also found that levels of dioxins are consistently higher in tissues from the general population of industrial countries and lower in persons from less industrialized countries (20, 38) . Elevated dioxin levels in heavily exposed workers have been demonstrated as long as 34 years after substantial exposure. Such extreme persistence of elevated dioxin levels demonstrates that human tissue dioxin measurement can be useful in documenting exposure for at least three decades after relatively high exposure (39, 40) . The association of PCDDs/PCDFs with relatively recent chemical industry synthesis of chlorinated organics was also demonstrated by the finding that levels of PCDDs/PCDFs in tissues of ancient (100-400-year-old) frozen Eskimo women from Alaska are very much lower than the levels currently found in humans from industrial countries (41) .
Despite demonstration of the usefulness of tissue measurements and for a variety of reasons, many recent otherwise sophisticated epidemiology studies have not used tissue measurements of dioxins to estimate exposure (42) (43) (44) (45) (46) (51) (52) (53) . They also include reports of increased reproductive, developmental, and endocrine alterations in the children of mothers with higher general population levels of dioxins (49, 50) . The studies of the Japanese Yusho rice oil incident, which occurred in 1968, reported an increase in birth defects, certain cancers, and cancer mortality (54, 55) . In the almost identical Taiwanese Yu-cheng rice oil poisoning, which occurred in 1979, an increase in birth defects and cognitive and behavioral impairment was reported in children born to mothers with Yu-cheng poisoning (56) . Initially both studies estimated dose by measuring PCBs, PCDFs, and PCDDs in the rice oil and estimating the amount of rice oil consumed. Later reports on Yusho and Yucheng included human tissue measurement of PCBs and PCDDs/PCDFs (55).
Conclusions
Obtaining human tissues for dioxin measurements was difficult initially because adipose tissue or milk was necessary to provide a sufficient amount of the lipophilic dioxins to measure. This required either Environmental Health Perspectives * Vol 106, Supplement 2 * April 1998 minor surgery (usually under local anesthesia) in the case of the fat tissue, or a nursing mother in the case of milk. With improved analytic methods, blood has become the tissue of choice. At first one 450-mi unit of blood, usually 0.3 to 0.6% lipid, was required for blood dioxin measurement. At present as little as 50 to 100 ml of blood is needed for most general population (from industrial countries) dioxin analyses. However, obtaining 100 ml of whole blood requires a healthy adult or multiple blood samples from a child or less-than-healthy adult. Less blood is needed when dioxin levels are elevated above current background levels.
Dioxins have long half-lives of elimination in humans and for the most part they remain in human tissue in the parent form rather than as metabolites. 1,2,3,4,7,8-hexachlorodibenzofuran ) a short time after exposure when the levels were higher, and slower rates of elimination later as levels declined. They report halflives of 2.0 to 2.5 years closer to the time of exposure when the PCDF levels were higher and of approximately 10 years when the levels were lower (62) .
Relatively Exposures to dioxins, dibenzofurans, PCBs, and related chemicals can be of concern for workers, persons living near contaminated sites, and fish-eaters consuming dioxin-contaminated fish. At the present time and with only a few exceptions (75) (76) (77) (78) , most researchers consider GC-MS the gold standard for documenting increased dioxin dose.
It is hoped that all future health studies will use the refined exposure estimates now available. Such improved exposure assessment should markedly improve epidemiology studies relating to the health effects caused by dioxins.
